QYUNS-B News

QYUNS-B: VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL DATA OF QX005N INJECTION FOR TREATMENT OF PRURIGO NODULARIS (PN) RELEASED AT THE 29TH ANNUAL MEETING OF CHINESE SOCIETY OF DERMATOLOGY

Jun 14 18:30

QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 6 16:39

QYUNS-B: VOLUNTARY ANNOUNCEMENTFIRST SUBJECT ENROLLMENT FORQX005N PHASE III CLINICAL TRIAL FOR THE TREATMENT OF PRURIGONODULARIS

May 29 18:49

QYUNS-B: CLARIFICATION ANNOUNCEMENT SUPPLEMENTAL NOTICE AND REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024

May 16 21:52

QYUNS-B: REVISED FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024

May 14 18:30

QYUNS-B: VOLUNTARY ANNOUNCEMENTQYUNS OBTAINED IND CLEARANCE FOR QX013N FOR TREATMENT OFCHRONIC SPONTANEOUS URTICARIA IN CHINA

May 9 21:01

QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 16:34

QYUNS-B: FORM OF PROXY FOR THE ANNUAL GENERAL MEETINGTO BE HELD ON FRIDAY, MAY 31, 2024

Apr 26 19:17

QYUNS-B: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 26 19:06

QYUNS-B: VOLUNTARY ANNOUNCEMENTBUSINESS UPDATE

Apr 25 16:30

QYUNS-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 8 19:10

QYUNS-B: ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS

Mar 19 22:48

QYUNS-B: List of Directors and their Roles and Functions

Mar 19 06:21

QYUNS-B: Terms of Reference of the Strategy and Development Committee

Mar 19 06:18

QYUNS-B: Terms of Reference of the Remuneration and Appraisal Committee

Mar 19 06:15

QYUNS-B: Terms of Reference of the Nomination Committee

Mar 19 06:11

QYUNS-B: Terms of Reference of the Audit Committee

Mar 19 06:08

QYUNS-B: Articles of Association

Mar 19 06:04

QYUNS-B: GLOBAL OFFERING

Mar 12 06:06

QYUNS-B: PHIP (1st submission)

Feb 26 22:32